Table 3.
Three-year relative survival (RS) expressed as percentages with 95% confidence interval (95%CI)
| Before CPP | During CPP | After CPP | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total | Non-CPP referred | CPP referred | ||||||||
| RS | (95%CI) | RS | (95%CI) | RS | (95%CI) | RS | (95%CI) | RS | (95%CI) | |
| CRC | 63.8 | (57.0;69.9) | 66.4 | (62.9;69.7) | 69.3 | (64.8;73.3) | 70.8 | (65.2;75.7) | 65.4 | (57.6;72.1) |
| Lung | 11.3 | (8.00;15.4) | 16.2 | (13.7;18.9) | 20.4 | (15.6;25.7) | 19.5 | (13.6;26.2) | 20.9 | (15.5;26.9) |
| Melanoma | 89.6 | (81.5;94.3) | 91.7 | (87.4;94.5) | 91.9 | (86.1;95.4) | 95.6 | (87.0;98.5) | 85.3 | (74.2;91.8) |
| Head & neck | 57.0 | (41.5;69.8) | 70.3 | (61.6;77.4) | 73.6 | (64.1;81.0) | 77.8 | (66.8;85.6) | 58.5 | (39.2;73.6) |
| Upper GI | 18.5 | (13.5;24.2) | 19.8 | (16.5;23.3) | 18.5 | (14.5;22.9) | 17.4 | (12.9;22.5) | a | |
| Gynaecological | 58.3 | (48.7;66.8) | 70.7 | (67.1;77.4) | 75.2 | (68.2;80.8) | 72.8 | (64.5;79.5) | 84.4 | (70.8;92.0) |
| Urinary system | 47.7 | (38.5;56.3) | 59.9 | (54.2;65.1) | 61.7 | (53.1;69.3) | 59.2 | (48.6;68.4) | a | |
| Total | 44.5 | (41.5;47.5) | 51.0 | (49.4;52.6) | 54.4 | (52.2;56.5) | 54.5 | (51.8;57.1) | 54.1 | (50.3;57.8) |
RS estimates are calculated using the complete approach and standardised using ICSS weights. Underlying mortality was accounted for using life tables. aCould not be computed due to a low number of cases